Latest "Reckitt Benckiser" News Stories

11:01 EDT 21st July 2018 | BioPortfolio

Here are the most relevant search results for "Reckitt Benckiser" found in our extensive news archives from over 250 global news sources.

More Information about Reckitt Benckiser on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Reckitt Benckiser for you to read. Along with our medical data and news we also list Reckitt Benckiser Clinical Trials, which are updated daily. BioPortfolio also has a large database of Reckitt Benckiser Companies for you to search.

Showing "Reckitt Benckiser" News Articles 1–25 of 81

Extremely Relevant

Research-Fazits zu Reckitt Benckiser, Roche, Vinci ...


Reckitt Benckiser steigt aus Bieterrennung für Pfizer-Sparte aus

Von Carlo Martuscelli LONDON (Dow Jones)--Reckitt Benckiser ist aus dem Bieterrennen um das Consumer-Health-Geschäft von Pfizer ausgestiegen. Der Konsumgüterhersteller teilte mit, er sei nur an ei...

Pfizer consumer health sale: Reckitt Benckiser plays down rumours

Reckitt Benckiser Group says it will be disciplined in its M&A strategy but remains silent on speculation it is buying Pfizerâs consumer healthcare business.

Reckitt will Pfizer-Sparte nicht mehr kaufen: Pfizer-Geschäft will das Geschäft mit rezeptfreien Gesundheitsprodukten ...

Pfizer-Geschäft will das Geschäft mit rezeptfreien Gesundheitsprodukten verkaufen. Interessent Reckitt Benckiser steigt jetzt aus dem Rennen aus.Der britische Konsumgüterkonzern Reckitt Benckiser h...

Reckitt Benckiser in talks to acquire Mead Johnson for $16.7bn

British consumer goods maker Reckitt Benckiser is in advance negotiations to acquire tye US infant formula manufacturer Mead Johnson Nutrition for $16.7bn.

GSK wins case against Reckitt Benckiser over misleading ad campaign

GlaxoSmithKline is celebrating as it emerges that the UK pharma giant triumphed in its legal battle against Reckitt Benckiser after accusing the rival firm of misleading consumers by directly comparing its product Nurofen to paracetamol in its advertising campaign, when GSK manufactures the branded version, Panadol. read more

Reckitt Benckiser quits bidding for Pfizer's consumer healthcare arm

Reckitt Benckiser has ended discussions with Pfizer about buying elements of the US company's consumer healthcare business. The health and hygiene consumer goods company said it did not want to buy...

Reckitt Benckiser drops plans to buy Pfizer's consumer healthcare business

Reckitt Benckiser (RB) has dropped plans to acquire Pfizer's consumer healthcare business, which is made up of several over-the-counter (OTC) products sold in more than 90 countries.

Pfizer’s €16bn OTC sale in doubt as GSK and Reckitt pull out of auction

The race to buy Pfizerâs OTC business â including Advil painkillers and Centrum vitamins â may have collapsed after both GlaxoSmithKline and Reckitt Benckiser officially walked away from the auction within days of each other.

Bloomberg: Glaxo, Reckitt Submit Bids For Pfizer's Consumer Business Unit

LONDON (dpa-AFX) - As per a report published in Bloomberg, GlaxoSmithKline plc (GSK.L, GSK) and Reckitt Benckiser Group plc (RBGPF.PK, RB.L) are the companies in race for the Pfizer's consumer bus...

GSK left as sole bidder for Pfizer consumer health unit

GlaxoSmithKline is understood to be the sole bidder for Pfizer’s $15-20bn consumer health unit after Reckitt Benckiser pulled out. Reckitt’s shares jumped after it published a short statement saying it had ended discussions with Pfizer, noting tha...

GlaxoSmithKline leads race to buy $20bn Pfizer unit

Drugmaker tops Reckitt Benckiser’s rival bid for consumer health business

GlaxoSmithKline in pole position for $20bn Pfizer unit

Rival Reckitt Benckiser falls back in the bidding for Advil maker

GSK drops bid to acquire Pfizer's consumer business

The decision comes as a surprise as GSK had appeared to be the leading contender to buy the unit after rival Reckitt Benckiser quit the auction process.

GlaxoSmithKline follows Reckitt Benckiser in bowing out of US$20bn auction for Pfizer Inc consumer division

Bidders seem to be dropping like flies and it's unclear just who is left in the auction

GlaxoSmithKline follows Reckitt Benckiser in bowing out of US$20bn auction for Pfizer consumer division

Bidders seem to be dropping like flies and it's unclear just who is left in the auction


Merck verkauft an P&G

Der Pharma- und Spezialchemiekonzern Merck ist sein Geschäft mit rezeptfreien Medikamenten endlich losgeworden. Nachdem sich Interessenten wie Nestle oder Reckitt Benckiser zurückgezogen hatten, ge...

Reckitt Benckiser pulls out of Pfizer consumer health auction

The Pfizer logo is seen at their world headquarters in Manhattan, New York, U.S., August 1, 2016. REUTERS/Andrew Kelly ), which sources familiar with the matter said was working on an offer for the business.

Guten Morgen mit Siemens Healthineers-IPO, Bayer, Adler Real Estate, TLG

RB/ LN - RECKITT BENCKISER 4Q COMP Umsatz +2%, erw. +2.1% SIE - Siemens kündigt heute IPO der Medizintechnik-Tochter an: Kreise SIE - HEALTHINEERS IPO WIRD ZWEITPLATZIERUNG BESTEHENDER SIEMENS-AKT....

Dividenden-Liebling GlaxoSmithKline: Kein Deal mit Pfizer - Aktie gibt Comeback

Nach Reckitt Benckiser hat sich auch GlaxoSmithKline aus dem Rennen um die zum Verkauf stehende Consumer-Health-Sparte von Pfizer zurückgezogen. Der Druck auf die Amerikaner wächst. Laut der Nachri...

STAT Plus: Pharmalittle: Trump says Gottlieb is a ‘star’; J&J bows out of race for Pfizer consumer biz

Johnson & Johnson has pulled out of the race to buy the Pfizer consumer health business, leaving GlaxoSmithKline and Reckitt Benckiser among those preparing bids.

Global Mouth Ulcer Treatment Drug Market Survey and Trend Research 2018 [Report Updated: 13012018] Prices from USD $2600

SummaryMouth ulcers, also known as canker sores, are normally small, painful lesions that develop in mouth or at the base of gums. They can make eating, drinking, and talking uncomfortable. Mouth ulcers aren't contagious and usually go away within one to two weeks.This report describes the development of the industry by upstream downstream, industry overall and development, key companies, as well...

GSK withdraws from running for Pfizer Consumer Health

GSK has announced that it has decided to pull out of the race to acquire Pfizer’s Consumer Health business, ending months of speculation. After fellow UK business Reckitt Benckiser dropped out of discussions with the US pharma giant, GSK had been the favourite to pick up the business but now, unless there was an unannounced eleventh hour bid, it looks like Pfizer will have to reassess its option...

GSK Is Now Favorite to Acquire Pfizer's Consumer Health Business

Now that Reckitt Benckiser has walked away from a deal, GlaxoSmithKline is now the favorite to acquire Pfizer's consumer health business.

GSK And Reckitt Opting Out Of Pfizer's Consumer Business Sale Speaks Volumes

Reckitt and GSK withdraw from negotiating on potential deals for with Pfizer's consumer business, leaving slim chances Pfizer will receive...  

Quick Search


News Quicklinks